Ability of azlocillin and tobramycin in combination to delay or prevent resistance development in Pseudomonas aeruginosa

The ability of combinations of azlocillin and tobramycin to prevent or delay resistance development in eight Pseudomonas aeruginosa isolates from cystic fibrosis (CF) patients was studied using chequerboard titration and in-vitro serial subculture. No isolate had developed resistance to tobramycin a...

Celý popis

Podrobná bibliografia

Vydané v:	Journal of antimicrobial chemotherapy Ročník 44; číslo 3; s. 389
Hlavní autori:	Wu, Y L, Scott, E M, Po, A L, Tariq, V N
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England 01.09.1999
Predmet:	Anti-Bacterial Agents - pharmacology Azlocillin - pharmacology Cystic Fibrosis - microbiology Drug Resistance, Microbial - physiology Drug Therapy, Combination - pharmacology Humans Microbial Sensitivity Tests Penicillins - pharmacology Pseudomonas aeruginosa - drug effects Pseudomonas aeruginosa - physiology Pseudomonas Infections - microbiology Tobramycin - pharmacology
ISSN:	0305-7453
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!